Does inflammation raise ferritin and suppress steroidogenesis?

Systemic inflammation exerts profound, distinct regulatory effects on iron storage markers and endocrine pathways.

Inflammatory Ferritin Elevation

• Mechanism of Action: Pro-inflammatory cytokines (such as IL-6, IL-1β, and TNF-α) activate transcriptional pathways like NF-κB to directly upregulate ferritin gene expression.
• Iron Sequestration: Cytokine-driven elevation of IL-6 upregulates the hormone hepcidin, which induces the degradation of the iron exporter ferroportin. This traps iron within macrophages and hepatocytes, further stimulating intracellular ferritin synthesis.
• Clinical Implications: Because ferritin acts as a positive acute-phase reactant, standard diagnostic thresholds for iron deficiency must be elevated (e.g., up to 70–100 μg/L) during active inflammation to prevent underdiagnosis.

Suppression of Steroidogenesis and SHBG

• Steroidogenesis Inhibition: TNF-α, IL-1β, and IL-6 directly impair steroidogenesis in steroidogenic cells. These cytokines downregulate critical proteins including StAR (blocking mitochondrial cholesterol transport), CYP11A1, CYP17A1, and 3β-HSD. TNF-α further inhibits transcription factors Nur77 and SF-1 via the NF-κB pathway.
• SHBG Downregulation: The claim that inflammation increases sex hormone-binding globulin (SHBG) is unsupported. In contrast, inflammatory cytokines suppress hepatic SHBG. Mechanistically, TNF-α (via NF-κB) and IL-1β (via MEK-1/2 and JNK MAPK) suppress the expression and activity of HNF-4α, the primary transcriptional activator of the SHBG promoter, leading to reduced circulating SHBG levels.

Bottom line

• Key takeaway: While inflammation elevates serum ferritin via hepcidin-driven iron trapping and directly suppresses steroidogenesis by inhibiting key regulatory enzymes, it actively decreases rather than increases SHBG by downregulating the transcription factor HNF-4α.